Westchester Medical Center and BioGenCell Open BioGenCell's Fourth Chronic Limb-Threatening Ischemia Clinical Trial Site in the United States

Westchester Medical Center (an academic affiliate of Touro University/New York Medical College) and BioGenCell have marked a milestone with the opening of a Phase II cell-therapy based clinical trial site for Chronic Limb-Threatening Ischemia (CLTI) in the United States, following Yale...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: TRI PDT Source Type: news